|
COG3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.209600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.787630E-01 |
| Normal-vs-Stage2 |
9.899400E-01 |
| Normal-vs-Stage3 |
1.569920E-04 |
| Normal-vs-Stage4 |
3.316800E-01 |
| Stage1-vs-Stage2 |
4.380600E-01 |
| Stage1-vs-Stage3 |
1.717350E-03 |
| Stage1-vs-Stage4 |
6.279200E-01 |
| Stage2-vs-Stage3 |
1.517970E-02 |
| Stage2-vs-Stage4 |
3.875400E-01 |
| Stage3-vs-Stage4 |
4.624200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.458200E-02 |
| Normal-vs-AfricanAmerican |
1.599370E-01 |
| Normal-vs-Asian |
9.269800E-02 |
| Caucasian-vs-AfricanAmerican |
9.098000E-01 |
| Caucasian-vs-Asian |
1.622640E-01 |
| AfricanAmerican-vs-Asian |
7.218200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.899600E-02 |
| Normal-vs-Female |
1.598430E-01 |
| Male-vs-Female |
3.399000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.256700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.785200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.257800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.852800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.486840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.353000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.255600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.542200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.037200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.111900E-02 |
| Normal-vs-Grade 2 |
7.069400E-01 |
| Normal-vs-Grade 3 |
8.012200E-04 |
| Normal-vs-Grade 4 |
1.190200E-01 |
| Grade 1-vs-Grade 2 |
1.573000E-01 |
| Grade 1-vs-Grade 3 |
3.663200E-03 |
| Grade 1-vs-Grade 4 |
2.448200E-02 |
| Grade 2-vs-Grade 3 |
9.796500E-04 |
| Grade 2-vs-Grade 4 |
1.501380E-01 |
| Grade 3-vs-Grade 4 |
6.943000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.748980E-01 |
| Normal-vs-ccB subtype |
3.24149999952894E-07 |
| ccA subtype-vs-ccB subtype |
1.11544107284089E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.657000E-01 |
| Normal-vs-N1 |
2.644500E-04 |
| N0-vs-N1 |
9.537700E-03 |
|
|
